Cataract drugs in development, 2023

GlobalData tracks 19 drugs in development for Cataract by 17 companies/universities/institutes. The top development phase for Cataract is preclinical, with 13 drugs in that stage.

Despite setback, AbbVie’s big bet on neuroscience has yet to play out

For AbbVie, the good news this week is that the failure of a high-profile schizophrenia drug in two key trials hardly marks its last opportunity

November 12, 2024

Grail faces uphill battle to get Medicare to cover its cancer screening test

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has

June 27, 2023

JJ Bienaimé is moving out of the C-suite after an 18-year run at BioMarin. And you likely know his successor

Feisty, stubborn Jean-Jacques Bienaimé is stepping down from the top post at BioMarin after an 18-year run with a string of highlights in 2023. And

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.